It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
The first drug shown to slow Alzheimer’s disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have rejected coverage.
Doctors also expect some patients will hesitate to take Leqembi due to its limited impact and potential side effects. They say it will take years to learn how best to deploy the drug and that work must be done to improve diagnosis.
“This is the start of a very exciting journey,” said Dr. Ambar Kulshreshtha, a suburban Atlanta family physician focused on dementia patients.
More than 6 million Americans, and millions more worldwide, have Alzheimer’s disease, the most common cause of dementia. There’s no cure, but Leqembi clears a sticky brain protein called amyloid that’s a key indicator of Alzheimer’s.
Studies showed that it can delay the progression of the disease by a few months when given to people with mild symptoms. Some experts say the delay may be too subtle for patients to notice.
Related articles
Norwegian Cruise Line, Wix.com rise; Cushman & Wakefield, Target fall, Monday, 5/20/2024
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Monday:Johnson Contro2024-05-22Xizang art exhibition celebrates creativity of students with disabilities
Yeshe Drolma, a hearing-impaired student from a special education school in Lhasa, the capital city2024-05-22EMILY PRESCOTT: Emma Stone's got a black belt in red carpet appearances
It's the go-to palette for celebrities looking to make an impression on that all-important red carpe2024-05-22China adds 7 ski resorts to national roster
China has expanded its list of national-level ski resorts with seven new destinations, further enric2024-05-22What's next for Iran after death of its president in crash?
JERUSALEM (AP) — The death of Iran’s president is unlikely to lead to any immediate changes in Iran’2024-05-22Beijing secure comeback win in Chinese Super League
Beijing Guoan rode on three goals from substitutes in eight minutes to rally past Meizhou Hakka 3-22024-05-22
atest comment